Veranova’s Macfarlan Smith subsidiary announced that it had completed a $10 million mid-scale API manufacturing expansion in Edinburgh, UK.  This new facility can produce highly active APIs as well as intermediates. It will meet the growing demand of generic opioid analgesics as well as anti-addiction drugs. The API manufacturing expansion is the first of two investments,…